Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01465113 · ClinicalTrials.gov registry record · Early Phase 1
Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus
A Early Phase 1 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 26
- Enrollment target
NCT01465113 is a Early Phase 1 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 26 participants.
The verdict
NCT01465113, a Early Phase 1 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study is being conducted to determine if vitamin D supplementation increases the level of a protein that may be involved in decreasing the risk of esophageal cancer in patients with Barrett's esophagus. Subjects with Barrett's esophagus will take vitamin D supplementation for 2-12 weeks depending on the severity of their condition, and receive an upper endoscopy procedure before and after vitamin D supplementation trial.
Interventions
- DRUG Metformin
- DRUG Omeprazole
- DRUG Vitamin D3
- PROCEDURE upper endoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2010-05 |
| Est. Completion | 2016-02 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01465113
The ClinicalTrials.gov registry entry for NCT01465113 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Metformin is the first listed.
NCT01465113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01465113 about?
NCT01465113 is a clinical study titled "Vitamin D Supplementation on 15-Prostaglandin Dehydrogenase Expression in Barrett's Esophagus". This study is being conducted to determine if vitamin D supplementation increases the level of a protein that may be involved in decreasing the risk of esophageal cancer in patients with Barrett's esophagus. Subjects with Barrett's esophagus will take vitamin D supplementation for 2-12 weeks dependi...
What is the current status of trial NCT01465113?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 26 participants. The study started on 2010-05. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01465113?
The interventions under investigation include: Metformin (DRUG), Omeprazole (DRUG), Vitamin D3 (DRUG), upper endoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT01465113?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.